Rotavirus NSP1 Inhibits Type I and Type III Interferon Induction

• Published in: Viruses Vol. 13; no. 4; p. 589
• Main Authors: Iaconis, Gennaro, Jackson, Ben, Childs, Kay, Boyce, Mark, Goodbourn, Stephen, Blake, Neil, Iturriza-Gomara, Miren, Seago, Julian
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 31-03-2021; MDPI
• Subjects: Adapter proteins; Antiviral agents; Binding sites; Epithelial cells; Epithelium; Gene expression; Infections; Interferon; Interferon regulatory factor 1; Interferon regulatory factor 3; Interferon regulatory factor 7; Intestine; IRF-1; IRF-3; Kinases; Mucosa; NSP1; NSP1 protein; Phosphorylation; Proteasomes; Rotavirus; Signal transduction; type I interferon; type III interferon; Viruses; type I interferon; NF-κB; NSP1; type III interferon; rotavirus; IRF-3; IRF-1; IRF-7
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v13040589

Type I interferons (IFNs) are produced by most cells in response to virus infection and stimulate a program of anti-viral gene expression in neighboring cells to suppress virus replication. Type III IFNs have similar properties, however their effects are limited to epithelial cells at mucosal surfaces due to restricted expression of the type III IFN receptor. Rotavirus (RV) replicates in intestinal epithelial cells that respond predominantly to type III IFNs, and it has been shown that type III rather than type I IFNs are important for controlling RV infections in vivo. The RV NSP1 protein antagonizes the host type I IFN response by targeting IRF-3, IRF-5, IRF-7, or β-TrCP for proteasome-mediated degradation in a strain-specific manner. Here we provide the first demonstration that NSP1 proteins from several human and animal RV strains antagonize type III as well as type I IFN induction. We also show that NSP1 is a potent inhibitor of IRF-1, a previously undescribed property of NSP1 which is conserved among human and animal RVs. Interestingly, all NSP1 proteins were substantially more effective inhibitors of IRF-1 than either IRF-3 or IRF-7 which has significance for evasion of basal anti-viral immunity and type III IFN induction in the intestinal epithelium.